Life Healthcare is bumping up its South African capital expenditure for the year to September 2024 to R2.1 billion to purchase a hospital it currently leases as well as spending on product development for its Life Molecular Imaging (LMI) unit.
In the year to the end of September 2023, Life Healthcare invested R1.5bn, up from R1.4bn year earlier, in capital expenditure covering continuing operations. Of this, maintenance capex for the year under review amounted to R1.2bn while growth capex stood at R366 million.
“In FY2024 we plan to spend R2.1bn on capital expenditure in SA, including R350m on the purchase of a hospital property currently leased. We also plan to spend R200m on capex for LMI, largely earmarked for investment into LMI’s product pipeline development,” the company said.
The planned…